Publications by authors named "Shi-Yu Ye"

Objective: To explore the overall survival and prognostic factors of patients over 50 years old with acute myeloid leukemia (AML).

Methods: The clinical data of 222 AML patients aged over 50 years in our hospital from January 2016 and June 2021 were retrospectively analyzed. Kaplan-Meier method was used to evaluate the overall survival (OS) rate, and Cox regression model to evaluate the prognostic factors.

View Article and Find Full Text PDF

In pyloric metaplasia, mature gastric chief cells reprogram via an evolutionarily conserved process termed paligenosis to re-enter the cell cycle and become spasmolytic polypeptide-expressing metaplasia (SPEM) cells. Here, we use single-cell RNA sequencing (scRNA-seq) following injury to the murine stomach to analyze mechanisms governing paligenosis at high resolution. Injury causes induced reactive oxygen species (ROS) with coordinated changes in mitochondrial activity and cellular metabolism, requiring the transcriptional mitochondrial regulator Ppargc1a (Pgc1α) and ROS regulator Nf2el2 (Nrf2).

View Article and Find Full Text PDF

Peritoneal metastasis is the leading cause of death for gastrointestinal cancers. The native and therapy-induced ascites ecosystems are not fully understood. Here, we characterize single-cell transcriptomes of 191,987 ascites cancer/immune cells from 35 patients with/without gastric cancer peritoneal metastasis (GCPM).

View Article and Find Full Text PDF

The purpose of this meta-analysis was to evaluate the efficacy and safety of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, in addition to standard anticancer therapy. Randomized controlled trials (RCTs) that evaluated the efficacy and safety of celecoxib-combined cancer therapy were systematically searched in PubMed and Embase databases. The endpoints were overall survival (OS), progression-free survival (PFS), disease-free survival (DFS), objective response rate (ORR), disease control rate (DCR), pathological complete response (pCR), and adverse events (AEs).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how the CXCR4 gene influences the effectiveness of Carfilzomib (CFZ) treatment in patients with multiple myeloma (MM).
  • Researchers analyzed data from CFZ-resistant and parental MM cell lines to identify key genes related to CFZ resistance using microarray data and protein-protein interaction networks.
  • Findings reveal that high levels of CXCR4 expression are linked to increased relapse rates and decreased overall survival in MM patients, suggesting CXCR4 could be a target for improving treatment responses in resistant cases.
View Article and Find Full Text PDF

Objective: To explore the effect of hypoxia on the chemosensitivity of B-acute lymphoblastic leukemia (B-ALL) cells to Vincristine (VCR) and the mechanisms.

Methods: B-ALL cells SUP-B15, Nalm-6 and RS4;11 were selected as the research objects. The cells were divided into the control group and the hypoxia mimic group (CoCl pretreatment).

View Article and Find Full Text PDF

Background: Clonal hematopoiesis (CH) can be found in various myeloid neoplasms (MN), such as myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN), also in pre-MDS conditions.

Methods: Cytogenetics is an independent prognostic factor in MDS, and fluorescence in-situ hybridization (FISH) can be used as an adjunct to karyotype analysis. In the past 5 years, only 35 of 100 newly diagnosed MDS and MDS/MPN patients were identified abnormalities, who underwent the FISH panel.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the importance of a targeted next-generation sequencing test for diagnosing myeloid malignancies in patients with blood disorders.
  • A total of 39 patients were analyzed, with 70.8% of those diagnosed with myeloid malignancies showing positive mutations, particularly in genes like ASXL1, TET2, and RUNX1.
  • The findings indicated that the targeted sequencing can enhance diagnosis and potentially guide treatment for patients, especially for those with myelodysplastic syndromes.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze clinical characteristics of 66 newly diagnosed essential thrombocytopenia (ET) patients, focusing on their mutation status (JAK2, CALR, MPL, or none).
  • Results showed that 69.7% had JAK2 mutations, with the average age significantly higher (63.2 years) than those with CALR mutations (51.8 years) or negative mutations (50.2 years).
  • The CALR mutation group exhibited lower white blood cell (WBC) and hemoglobin (Hb) levels, while 30.3% of all patients experienced thrombus or embolism, with some also facing complications like hyperkalemia.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the effectiveness and prognosis of acute myeloid leukemia (AML) patients based on chromosome karyotype abnormalities by investigating clinical features and treatment responses in 91 patients.
  • Results showed that while there was no significant difference in complete remission and overall response rates between patients with normal and abnormal karyotypes, those with abnormal karyotypes experienced higher recurrence rates and longer relapse-free survival for normal karyotype patients.
  • The conclusion drawn indicates that having an abnormal karyotype is an independent prognostic factor in AML, with a particular mention that monosomal karyotypes are associated with poorer outcomes and higher recurrence rates.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to understand how Bruton's tyrosine kinase (Btk) is regulated and its underlying mechanisms.
  • Researchers used various treatments to assess the mRNA and protein levels of Btk and found that its expression is influenced by factors like proteasome inhibitors and phorbol esters (PMA).
  • The results indicate that Btk is regulated through ubiquitination, particularly by the E3 ligase Cbl, impacting its stability and activation in cells.
View Article and Find Full Text PDF

Objective: To study the effect of homoharringtonine (HHT) alone or combined with 3-methyladenine (3-MA) , an autophagy inhibitor, on the apoptosis and autophagy of K562 cells.

Methods: K562 cells were treated with HHT(10 ng/ml) or HHT(10 ng/ml) combined with 3-MA (1.5 mmol/L) for 1 to 8 days.

View Article and Find Full Text PDF

Objective: To explore the effect of homoharringtonine(HHT) combined with imatinib(IM) on proliferation and apoptosis of K562/G01 cells and its potential mechanism.

Methods: K562/G01 cells were cultured with HHT and/or IM. CCK-8 assay was used to detect cell proliferation.

View Article and Find Full Text PDF

Objective: To investigate the effects of AMPK agonist Acadesine (AICAR) on growth inhibition of K562 cells and their sensitivity to imatinib (IM).

Methods: K562 cells were cultured with different concentrations of AICAR alone or its combination with IM for 48 hours, the CCK-8 assay was used to detect cell proliferation, the cell cycle distribution and apoptosis were analyzed by flow cytometry. The expression levels of Cyclin D1, Cyclin E1 and Caspase 3 protein were determined by Western blot.

View Article and Find Full Text PDF

This study was aimed to investigate the effect of homoharringtonine (HHT) on K562 cell proliferation, apoptosis and expression of BCL-2 and NF-κB proteins. The cells proliferation was assayed with MTT method, the cell apoptosis, cell cycle and BCL-2 expression were analyzed with flow cytometry, NF-κB protein expression was detected with Western blot. The results showed that HHT concentration-dependently inhibited proliferation of K562 cells, the IC50 at 48 h was 43.

View Article and Find Full Text PDF

The study was aimed to investigate the synergistically effect of interferon-α (IFN-α) and homoharringtonine (HHT) on the proliferation, apoptosis, cell cycle of K562 cells and the expression of β-catenin. The proliferation, apoptosis, cell cycle and β-catenin mRNA expression of K562 cells treated with IFN-α and/or HHT were assayed with MTT, flow cytometry or RT-PCR respectively. The results showed that HHT alone, but not IFN-α alone, displayed a proliferation inhibition, apoptosis induction, G(0)/G(1) phase block and down-regulation of β-catenin expression in K562 cells with concentration- and time-dependent manners.

View Article and Find Full Text PDF